WW International, Inc. (WW)

Achilles Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts that cover Achilles Therapeutics stock have a consensus rating of "Hold" and an average price target of $35.25, which forecasts a -15.37% decrease in the stock price over the next year. The lowest target is $0.75 and the highest is $60.

Price Target: $35.25 (-15.37%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$0.75	$35.25	$45	$60
Change	-98.20%	-15.37%	+8.04%	+44.06%

Analyst Ratings

The average analyst rating for Achilles Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	3	3	3	3	2	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	4	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lauren Schenk Morgan Stanley	Morgan Stanley	Hold Initiates $45	Hold	Initiates	$45	+8.04%	Aug 1, 2025
Alex Fuhrman LUCID CAPITAL MARKETS	LUCID CAPITAL MARKETS	Strong Buy Initiates $60	Strong Buy	Initiates	$60	+44.06%	Jul 8, 2025
Stephanie Davis Barclays	Barclays	Sell Maintains $0.75	Sell	Maintains	$0.75	-98.20%	Oct 10, 2024
Jack Wallace Guggenheim	Guggenheim	Strong Buy Maintains $12 → $6	Strong Buy	Maintains	$12 → $6	-85.59%	Aug 2, 2024
Michael Lasser UBS	UBS	Hold Maintains $2.1 → $1	Hold	Maintains	$2.1 → $1	-97.60%	Aug 2, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

737.08M

Decreased by -6.21%

from 785.92M

Revenue Next Year

734.68M

Decreased by -0.33%

from 737.08M

EPS This Year

-0.27

from -4.34

EPS Next Year

-0.26

from -0.27

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jan 2, 2021	Jan 1, 2022	Dec 31, 2022	Dec 30, 2023	Dec 28, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.38B	1.21B	1.04B	889.55M	785.92M	737.08M	734.68M	797.98M
Revenue Growth	-2.49%	-12.12%	-14.15%	-14.45%	-11.65%	-6.21%	-0.33%	8.62%
EPS	1.07	0.95	-3.65	-1.46	-4.34	-0.27	-0.26	0.01
EPS Growth	-37.79%	-11.22%	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	4,043.69
No. Analysts	-	-	-	-	-	6	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	805.9M	824.3M	868.7M
Avg	737.1M	734.7M	798.0M
Low	658.0M	619.8M	707.8M

Revenue Growth

Revenue Growth	2025	2026	2027
High	2.5%	11.8%	18.2%
Avg	-6.2%	-0.3%	8.6%
Low	-16.3%	-15.9%	-3.7%

EPS Forecast

EPS	2025	2026	2027
High	-0.13	-0.13	0.07
Avg	-0.27	-0.26	0.01
Low	-0.46	-0.38	-0.05

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.